תרגול אנסין – חלק ב – אנסין 10

Tuberculosis is one of the oldest infectious diseases known to humankind, yet it continues to claim the lives of millions each year. Roughly a quarter of the world’s population is estimated to be infected with latent TB, and about 10 million people develop the active disease annually. It proves fatal for nearly 1.5 million individuals every year, with the majority of deaths occurring in low- and middle-income countries. Children and people with weakened immune systems, particularly those with HIV, are most vulnerable.

The connection between tuberculosis and poverty is deeply entrenched. Overcrowded housing, poor nutrition, and limited access to healthcare create ideal conditions for the disease to spread. “TB thrives where inequality is greatest,” notes epidemiologist Dr. Amina Khalid. Reducing TB rates through better treatment could therefore serve as an effective driver of social and economic development. However, pharmaceutical research into new drugs and vaccines has been slow, partly because TB primarily affects populations with little ability to pay for costly treatments.

Despite this, the international community has made some notable efforts. The World Health Organization’s (WHO’s) End TB Strategy aims to reduce TB deaths by 90% by 2035, employing measures such as improved diagnostic tools, shorter drug regimens, and preventative therapy for those at risk. Additionally, the Global Fund to Fight AIDS, Tuberculosis, and Malaria has supported the distribution of medications and the training of healthcare workers in affected regions.

Nevertheless, these initiatives are severely underfunded. Experts estimate that fully financing the fight against TB would require over $10 billion annually, yet current spending falls far short of this figure. Economists stress that the investment would ultimately pay off: not only would it save millions of lives, but it would also significantly reduce the economic losses caused by TB-related illness and death. In the long term, the cost of inaction far outweighs the cost of action.